The company is a medical devices company that has developed a novel technology for site directed, electronic driven radiation therapy for the treatment of cancer. The company’s product delivers high doses of radiation directly to tumors using a miniaturized electronic X-ray source, rather than radioactive chemicals. Using this type of electronic radiation source increases the safety of radiation therapy since the radiation can be turned on and off, unlike chemical radiation sources that continuously emit radiation. Furthermore, the company’s product delivers radiation to tumor sites directly, thereby preserving healthy surrounding tissue. The company’s technology enables physicians to more readily treat with radiation without the worry of systemic side effects, significantly increasing patient’s treatment regimens and positive prognosis.